Literature DB >> 15331608

Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and integrin alphav mediate survival signals through focal adhesion kinase.

Yan Zhang1, Hai Lu, Paul Dazin, Yvonne Kapila.   

Abstract

Resistance to anoikis, or apoptosis triggered by detachment from the extracellular matrix (ECM), lengthens the survival of malignant cells, facilitating reattachment and colonization of secondary sites. To examine the molecular mechanisms underlying resistance to anoikis in human oral squamous cell carcinoma (SCC) cells, we cultured human squamous carcinoma (HSC-3) cells in suspension on plates coated with poly-2-hydroxyethyl methacrylate, which blocks access to the ECM. Cells in suspension that formed multicellular aggregates had significantly lower levels of apoptosis than single cells. Aggregates, but not single cells, had high levels of fibronectin. Preincubation with a cyclic arginine-glycine-aspartic acid peptide or fibronectin-blocking antibody significantly increased anoikis. Single cells had markedly lower expression of the integrin alpha(v) receptor than aggregates. Blocking alpha(v) function with a blocking antibody or by transfection with an antisense oligonucleotide increased apoptosis and inhibited aggregation. In single cells but not aggregates, phosphorylation of the integrin-associated focal adhesion kinase (FAK) at tyrosine 397 was reduced, and p53 levels were increased. Apoptosis was increased by blocking FAK with an antisense oligonucleotide and reduced by blocking p53. These findings show that SCC cells escape suspension-induced anoikis by forming multicellular aggregates that avail themselves of fibronectin survival signals mediated by integrin alpha(v). Single cells in suspension that do not form aggregates undergo anoikis because of decreased FAK phosphorylation and increased p53 levels. Thus, SCC cells appear to use neighboring cells and the ECM molecule FN to promote the metastatic phenotype.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331608     DOI: 10.1074/jbc.M407953200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Expression of αV-integrins in uterine serous papillary carcinomas; implications for targeted therapy with intetumumab (CNTO 95), a fully human antagonist anti-αV-integrin antibody.

Authors:  Marta Bellone; Emiliano Cocco; Joyce Varughese; Stefania Bellone; Paola Todeschini; Karim El-Sahwi; Luisa Carrara; Federica Guzzo; Peter E Schwartz; Thomas J Rutherford; Sergio Pecorelli; Deborah J Marshall; Alessandro D Santin
Journal:  Int J Gynecol Cancer       Date:  2011-08       Impact factor: 3.437

Review 2.  Targeting the p53 pathway.

Authors:  Vita M Golubovskaya; William G Cance
Journal:  Surg Oncol Clin N Am       Date:  2013-07-30       Impact factor: 3.495

3.  A transfection method of PS-asODNs targeting ANGPTL4 in multicellular structures of hepatocarcinoma cell line.

Authors:  Q Kong; G Wu; L Han; Z Zhang; J Du; W Sun; L Cao
Journal:  Cancer Gene Ther       Date:  2015-04-24       Impact factor: 5.987

4.  CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis.

Authors:  Hui Liu; Shao-En Ong; Kwabena Badu-Nkansah; Jeffrey Schindler; Forest M White; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

5.  Imperatorin sensitizes anoikis and inhibits anchorage-independent growth of lung cancer cells.

Authors:  Kanuengnit Choochuay; Preedakorn Chunhacha; Varisa Pongrakhananon; Rataya Luechapudiporn; Pithi Chanvorachote
Journal:  J Nat Med       Date:  2012-10-30       Impact factor: 2.343

6.  NK4, an HGF antagonist, prevents hematogenous pulmonary metastasis by inhibiting adhesion of CT26 cells to endothelial cells.

Authors:  Takeshi Kubota; Hiroaki Taiyoh; Atsushi Matsumura; Yasutoshi Murayama; Daisuke Ichikawa; Kazuma Okamoto; Hitoshi Fujiwara; Hisashi Ikoma; Masayoshi Nakanishi; Shojiro Kikuchi; Chouhei Sakakura; Toshiya Ochiai; Yukihito Kokuba; Hiroki Taniguchi; Teruhisa Sonoyama; Kunio Matsumoto; Toshikazu Nakamura; Eigo Otsuji
Journal:  Clin Exp Metastasis       Date:  2009-02-21       Impact factor: 5.150

Review 7.  Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression.

Authors:  Cassandra L Buchheit; Kelsey J Weigel; Zachary T Schafer
Journal:  Nat Rev Cancer       Date:  2014-08-07       Impact factor: 60.716

8.  SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis.

Authors:  Hailing Cheng; Pixu Liu; Zhigang C Wang; Lihua Zou; Stephanie Santiago; Victoria Garbitt; Ole V Gjoerup; J Dirk Iglehart; Alexander Miron; Andrea L Richardson; William C Hahn; Jean J Zhao
Journal:  Sci Signal       Date:  2009-07-21       Impact factor: 8.192

9.  Cell aggregation induces phosphorylation of PECAM-1 and Pyk2 and promotes tumor cell anchorage-independent growth.

Authors:  Xing Zhang; Li-hua Xu; Qiang Yu
Journal:  Mol Cancer       Date:  2010-01-14       Impact factor: 27.401

10.  Receptor-interacting protein shuttles between cell death and survival signaling pathways.

Authors:  Pachiyappan Kamarajan; Julius Bunek; Yong Lin; Gabriel Nunez; Yvonne L Kapila
Journal:  Mol Biol Cell       Date:  2009-12-02       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.